Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Intermediate-risk cytogenetic acute myeloid leukemia with an internal tandem duplication of FLT3 (FLT3-ITD) is associated with a high risk of relapse, and is now a standard indication for allogeneic stem cell transplantation. Nevertheless, most studies supporting this strategy have been performed in...

Descripción completa

Detalles Bibliográficos
Autores principales: Poiré, Xavier, Labopin, Myriam, Polge, Emmanuelle, Passweg, Jakob, Craddock, Charles, Blaise, Didier, Cornelissen, Jan J., Volin, Liisa, Russell, Nigel H., Socié, Gérard, Michallet, Mauricette, Fegueux, Nathalie, Chevallier, Patrice, Brecht, Arne, Hunault-Berger, Mathilde, Mohty, Mohamad, Esteve, Jordi, Nagler, Arnon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792270/
https://www.ncbi.nlm.nih.gov/pubmed/29242299
http://dx.doi.org/10.3324/haematol.2017.178251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792270/
https://www.ncbi.nlm.nih.gov/pubmed/29242299
http://dx.doi.org/10.3324/haematol.2017.178251

Ejemplares similares